Xiaohong Ma

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Diabetic Nephropathy

Inflammatory Response

Lipopolysaccharide Induced

Top Venues

Nephrology (Carlton, Vic.)

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaohong Ma, Guandong Li, Yufeng Shi, Zhitao Shang
Rehmapicrogenin attenuates lipopolysaccharide-induced podocyte injury and kidney dysfunctions by regulating nuclear factor E2-related factor 2/antioxidant response element signalling. Nephrology (Carlton, Vic.) 29 (8) (2024)
Xiaohong Ma, Guandong Li, Yufeng Shi, Zhitao Shang
Rehmapicrogenin attenuates lipopolysaccharide-induced podocyte injury and kidney dysfunctions by regulating nuclear factor E2-related factor 2/antioxidant response element signalling. Nephrology (Carlton, Vic.) (2024)
Xiaohong Ma, Guandong Li, Yufeng Shi, Zhitao Shang
Rehmapicrogenin attenuates lipopolysaccharide-induced podocyte injury and kidney dysfunctions by regulating nuclear factor E2-related factor 2/antioxidant response element signalling. Nephrology (Carlton, Vic.) 29 (8) (2024)
Xiaohong Ma, Guandong Li, Yufeng Shi, Zhitao Shang
Rehmapicrogenin attenuates lipopolysaccharide-induced podocyte injury and kidney dysfunctions by regulating nuclear factor E2-related factor 2/antioxidant response element signalling. Nephrology (Carlton, Vic.) 29 (8) (2024)